PART I Overview Neuraxis, Inc. (we, us, the Company or Neuraxis) is a first-to-market growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. With several indications in the market and additional clinical trials of Percutaneous Electrical Nerve Field Stimulation (PENFS) in multiple pediatric and adult co...
Q2 FY2026 — expected 2026-09-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-19 | 2025-12-31 | 0001493152-26-011505 | EDGAR | 88K words |
| 2025-03-20 | 2024-12-31 | 0001493152-25-010984 | EDGAR | — |
| 2024-04-16 | 2023-12-31 | 0001493152-24-014832 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001493152-25-021547 | EDGAR | 24K words |
| 2025-08-12 | 2025-06-30 | 0001641172-25-023100 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001641172-25-009571 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044538 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001493152-24-030875 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001493152-24-020692 | EDGAR | — |
| 2023-11-20 | 2023-09-30 | 0001493152-23-042163 | EDGAR | — |
| 2023-09-22 | 2023-06-30 | 0001493152-23-033460 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-10-24 | 0001493152-25-019186 | EDGAR | 1K words |
| 2025-10-23 | 0001493152-25-019136 | EDGAR | — |
| 2025-09-02 | 0001641172-25-026158 | EDGAR | — |
| 2025-07-03 | 0001641172-25-017723 | EDGAR | — |
| 2025-06-04 | 0001641172-25-013632 | EDGAR | — |
| 2025-05-28 | 0001641172-25-012698 | EDGAR | — |
| 2025-05-22 | 0001641172-25-011973 | EDGAR | — |
| 2025-05-21 | 0001641172-25-011939 | EDGAR | — |
| 2025-01-08 | 0001493152-25-001323 | EDGAR | — |
| 2024-11-25 | 0001493152-24-047623 | EDGAR | — |
57 total filings indexed. 36 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001933567 |
| Ticker | NRXS |
| Exchange | NYSE |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | DE |
| Website | https://www.neuraxis.com |
| Listed | 2023-08-09 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report